Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 4 | Journal of Neuroinflammation

Figure 4

From: Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma

Figure 4

Role of PPAR-α, PPAR-γ, and PPAR-δ in palmitoylethanolamide-induced inhibition of inducible nitric oxide synthase expression. Spinal cord injury (SCI) induced an increase in inducible nitric oxide synthase (iNOS) expression evaluated by western blot analysis. Palmitoylethanolamide (PEA) post-treatment significantly reduced the levels of this protein in spinal cord homogenates. Either pretreatment with GW9662 (1 mg/kg) or GSK0660 (1mg/kg) counteracted the anti-inflammatory action of PEA (A). Mice with genetic absence of the peroxisome proliferator-activated receptor (PPAR)-α receptor exhibited increased expression of iNOS when compared with that observed in the SCI wildtype (WT) group and PEA was not able to reduce the expression of this enzyme in injured PPAR-αKO mice (B). *P <0.05 vs. sham WT; **P <0.01 vs. sham WT group; ##P <0.01 vs. SCI WT group.

Back to article page